Emv Capital (EMVC) RNS Announcements

Add to Alert list
Date Time Source Announcement
07 Apr 2016 07:00 AM
RNS
Annual Financial Report
05 Apr 2016 07:00 AM
RNS
Netscientific Appoints Ian Postlethwaite as CFO
30 Mar 2016 07:00 AM
RNS
ProAxsis Forms Scientific Advisory Board
24 Mar 2016 07:00 AM
RNS
Notice of Results
16 Mar 2016 07:00 AM
RNS
Wanda Forms Scientific Advisory Board
07 Mar 2016 02:00 PM
RNS
Adoption of reduced disclosure framework
01 Mar 2016 01:00 PM
RNS
Vortex co-founder receives US Presidential award
29 Feb 2016 07:00 AM
RNS
Wanda and Dignity Health launch OncoVerse platform
17 Feb 2016 07:00 AM
RNS
NetScientific appoints Prof. Stephen Smith as NED
09 Feb 2016 11:05 AM
RNS
PDS Biotechnology partners with NCI
08 Feb 2016 03:14 PM
RNS
Grant of Options to Director
26 Jan 2016 07:00 AM
RNS
Directorate Change
20 Jan 2016 11:09 AM
RNS
PDS Biotechnology adds drug development executives
06 Jan 2016 07:00 AM
RNS
Glycotest Inc. appoints medical advisory board
04 Jan 2016 07:00 AM
RNS
WANDA signs contract with HRS
16 Dec 2015 07:00 AM
RNS
Lawrence Cohen appointed as CEO of Glycotest Inc.
14 Dec 2015 07:00 AM
RNS
Appointment of Gene Walther as Vortex CEO
03 Dec 2015 07:00 AM
RNS
ProAxsis' ProteaseTagT research update
30 Nov 2015 07:00 AM
RNS
ProAxsis presents data to validate its immunoassay
16 Nov 2015 07:00 AM
RNS
Issue of Equity
11 Nov 2015 07:00 AM
RNS
Holding(s) in Company
10 Nov 2015 07:00 AM
RNS
Grant of Options
06 Nov 2015 12:14 PM
RNS
Result of General Meeting
06 Nov 2015 07:00 AM
RNS
Result of Placing and Further Allotment of Shares
03 Nov 2015 04:29 PM
RNS
Holding(s) in Company
21 Oct 2015 01:52 PM
RNS
Posting of Circular
01 Oct 2015 07:00 AM
RNS
Proposed Placing and Fund Raising to raise c.£20m
01 Oct 2015 07:00 AM
RNS
Half Yearly Report
18 Sep 2015 07:00 AM
RNS
Divestment of Shareholding in Frontier BioSciences
16 Sep 2015 01:01 PM
RNS
Holding(s) in Company
15 Sep 2015 07:00 AM
RNS
Vortex BioSciences granted critical patent
09 Sep 2015 01:00 PM
RNS
Steve Curd appointed as CEO of Wanda
07 Aug 2015 07:00 AM
RNS
Divestment of non-core assets to align portfolio
04 Aug 2015 07:00 AM
RNS
ProAxsis launches first-in-class ProteaseTag test
15 Jul 2015 07:00 AM
RNS
Key patent granted for Glucosense's technology
22 Jun 2015 01:19 PM
RNS
Results of Annual General Meeting
22 Jun 2015 07:00 AM
RNS
AGM Statement
05 Jun 2015 05:46 PM
RNS
Notification of Major Interest in Shares
05 Jun 2015 05:42 PM
RNS
Notification of Major Interest in Shares
05 Jun 2015 05:38 PM
RNS
Notification of Major Interest in Shares
05 Jun 2015 02:00 PM
RNS
Notification of Major Interest in Shares
05 Jun 2015 02:00 PM
RNS
Notification of Major Interest in Shares
28 May 2015 12:02 PM
RNS
PDS Biotechnology reports positive Phase I results
18 May 2015 07:00 AM
RNS
Notice of AGM and Annual Report & Accounts
15 May 2015 07:00 AM
RNS
Capital Markets Day
11 May 2015 07:00 AM
RNS
Dr. François R. Martelet appointed as CEO
07 May 2015 07:00 AM
RNS
NetScientific invests in Neumitra
01 May 2015 07:00 AM
RNS
NetScientific Forms New Digital Health Company
29 Apr 2015 09:00 AM
RNS
NetScientific Capital Markets Day
01 Apr 2015 07:00 AM
RNS
Change of Adviser

EMV Capital is a London venture capital company that invests in early-stage, IP-rich, technology and life sciences companies in the UK and internationally.

It is listed on AIM under the ticker EMVC.

EMVC share price launched at 1,620p in 2013.

UK 100

Latest directors dealings